Posts Tagged ‘Bipolar’

Latuda Changes its Spots

Thursday, February 9th, 2017

We’ve written previously about Latuda, an antidepressant. Now, the TV commercials for this dangerous psychiatric drug are claiming that it is for “bipolar depression” because that is different than just plain old depression.

The Latuda web site says that bipolar depression refers to the depressive phase of bipolar disorder, which is “different from other forms of depression,” having different “treatments.” In 2014 Latuda was number 95 on the list of top selling psychiatric drugs. It is estimated that about one in six American adults are taking at least one psychiatric drug.

What a crock!

This is akin to a public relations technique known as “propaganda by redefinition of words.” This is not a natural evolution of language, it is a deliberate propaganda technique to change public opinion, in this case to the advantage of the psycho-pharmaceutical industry by boosting sales of this drug for a new diagnosis.

The way to do this is to get the new definition repeated as often as possible; in this case through television and magazine ads.

Ah, so Johnny no longer has “depression”, he has “bipolar depression” — disassociating negative connotations of “depression” from the word by making a new term which miraculously can now be “treated” with this drug.

Regardless of the hokey diagnosis, still no one knows how this drug “works”; and the lengthy list of adverse reactions — well, that’s just the way it “works.”

This is also related to the psychiatric tendency to describe rather than to cure. So there are all kinds of bipolar now, and all kinds of depression, each with their own entry in the DSM and potentially their own “treatment”. In DSM-IV there were eight separate line items for bipolar diagnoses, and eight separate line items for various forms of depression. The DSM-V codes expand that to 58 line items for bipolar and 75 for depression.

Having all these different terms for essentially the same thing means that it is easier to say someone has it just by saying a big word. And psychiatrists have set themselves up as the only authorities who know what it means. Go ahead, say “Amphetamine (or other stimulant)-induced bipolar and related disorder, With moderate or severe use disorder” three times fast. Well, maybe not easier for you to say.

Talk about “fake news!” It’s all the rage now to point to various media and call the news fake. So we’re calling this news about “bipolar depression” totally fake. Fortunately, the real news can be found with diligent observation. Please do so! Find Out! Fight Back!

The Havering Crowd

Friday, July 3rd, 2015

The Havering Crowd

haver – verb
gerund or present participle: havering
[Scottish] talk foolishly; babble.
“Tom havered on.”
[British] act in a vacillating or indecisive manner.
“Most people giggle at their havering and indecision.”

Psychiatry and psychology employ havering as a method of professional communication. Otherwise known as “psychobabble,” this speech mechanism can put those unaware of its nature in a confused state.

psychobabble – noun
a form of speech or writing that uses psychological jargon, buzzwords, and esoteric language to create an impression of truth or plausibility

Googling the word “psychobabble” returns 456,000 results. It’s a popular pastime.

The word “psychobabble” came into popular use after the 1977 publication of Psychobabble: Fast Talk and Quick Cure in the Era of Feeling by R. D. Rosen, leading to another interesting definition: jargon speech that is heavily based on experience and emotion instead of well-known science.

Here is an example: bipolar. Yes, the word “bipolar” is a classic example of psychobabble, because when people claim they are bipolar they’re really saying that they are just moody. Saying you’re bipolar abdicates all responsibility for the control of your emotions.

Scanning the brains of children and adolescents labeled with ADHD is one of the latest psychobabble ideas being used in an attempt to bring some credibility to this fraudulent diagnosis, demonstrating that psychiatrists are still looking for an answer to justify the widespread drugging of children and adolescents.

Of course, the biggest psychobabble scam is the Diagnostic and Statistical Manual of Mental Disorders (DSM). And if you chewed on a page from the DSM while reciting one of its fraudulent diagnoses, you could be accused of havering your babble and eating it, too.

Shift Work Disorder

Sunday, September 8th, 2013

Shift Work Disorder

Circadian Rhythm Sleep-Wake Disorder, also called Shift Work Disorder, classified in the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, fifth edition) under “sleep-wake disorders”, is a way for the psycho-pharmaceutical industry to sell drugs to people who work nights or rotating shifts and who may experience difficulty adjusting to this sleep-wake rhythm. The implication that this is some kind of mental illness or disorder is most invalidating and simply untrue.

I myself worked a rotating night shift once upon a time, and it was pretty obvious that any sleep-wake discomfort I experienced was simply that and not any kind of mental illness. I found my own way of getting enough sleep without drugs.

“If you work non-traditional hours and struggle to stay awake at work, you may be experiencing excessive sleepiness.” However, for those who buy in to the psychiatric pill-pushers, they can get NUVIGIL® (armodafinil), an addictive, stimulant-like psychiatric drug for adults who cannot stay awake due to “shift work disorder.” Of course, like many psychiatric drugs, possible side effects are headache, nausea, dizziness, insomnia, depression, anxiety, hallucinations, suicide, and aggression. Note that this drug is not a cure for any condition, and is only used to make a person stay awake while working. Of course, the manufacturer warns the user not to drive or operate machinery while taking the drug, so one is not really sure what benefit it could possibly have in any case.

Teva Pharmaceutical Industries tried to get the FDA to approve Nuvigil for bipolar depression symptoms, but the results from the “Final Phase III Study of Patients with Major Depression Associated with Bipolar I Disorder” failed to show that it was more effective than a placebo.

The precise mechanism through which armodafinil is thought to promote wakefulness is unknown, but they think it has a similarity in action to amphetamine and methylphenidate, with some kind of effect in the brain involving dopamine and other chemicals. But they want you to try it out and let them know if it works. What do you think?

Please forward this newsletter to your family, friends and associates, and recommend that they subscribe.